Chidozie Ugwumba sold $184k of HLSQ
other at BiomX Inc.. 288,619 shares at an average of $0.64, traded Aug 10, 2022, filed Nov 14, 2022.
Score components
- +8RoleOther
- +12Trade size$184k at market
- 0Share of holdings soldSold 7.9% of holdings
- 0ClusterNo other insider selling within 14 days
What happened after comparable sells
Same side and tier, against the S&P 500, at 1, 3 and 6 months. Shown to Pro users; the whole table is on the backtest page.
Price around the trade, and since
From a quarter before the trade to today. The arrow is the trade, the circle the day the filing reached EDGAR, which is the first day anyone outside could act; the dotted line is the S&P 500 rebased to that day's close.
Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value; the dashed line is the close on the filing day, the dotted line SPY rebased to it.Charts by TradingView Lightweight Charts™
Rows in this filing
Every transaction in Form 4 0001014108-22-000161, as filed. Open on EDGAR
| Date | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|
| Aug 10, 2022 | SOpen-market sale Common Stockindirect: By SymBiosis, LLC | -17,769 | $0.74 | $13k | 3,620,077 | Nov 14, 2022 |
| Aug 11, 2022 | SOpen-market sale Common Stockindirect: By Symbiosis, LLC | -9,824 | $0.74 | $7,309 | 3,610,253 | Nov 14, 2022 |
| Aug 12, 2022 | SOpen-market sale Common Stockindirect: By Symbiosis, LLC | -11,406 | $0.73 | $8,372 | 3,598,847 | Nov 14, 2022 |
| Aug 15, 2022 | SOpen-market sale Common Stockindirect: By SymBiosis, LLC | -7,200 | $0.75 | $5,378 | 3,591,647 | Nov 14, 2022 |
| Aug 16, 2022 | SOpen-market sale Common Stockindirect: By SymBiosis, LLC | -8,563 | $0.73 | $6,242 | 3,583,084 | Nov 14, 2022 |
| Aug 17, 2022 | SOpen-market sale Common Stockindirect: By SymBiosis, LLC | -21,335 | $0.69 | $15k | 3,561,749 | Nov 14, 2022 |
| Aug 18, 2022 | SOpen-market sale Common Stockindirect: By SymBiosis, LLC | -7,764 | $0.68 | $5,303 | 3,553,985 | Nov 14, 2022 |
| Aug 19, 2022 | SOpen-market sale Common Stockindirect: By SymBiosis, LLC | -14,600 | $0.64 | $9,329 | 3,539,385 | Nov 14, 2022 |
| Aug 22, 2022 | SOpen-market sale Common Stockindirect: By SymBiosis, LLC | -5,000 | $0.66 | $3,285 | 3,534,385 | Nov 14, 2022 |
| Aug 23, 2022 | SOpen-market sale Common Stockindirect: By SymBiosis, LLC | -5,900 | $0.64 | $3,764 | 3,528,485 | Nov 14, 2022 |
| Aug 24, 2022 | SOpen-market sale Common Stockindirect: By SymBiosis, LLC | -8,665 | $0.65 | $5,650 | 3,519,820 | Nov 14, 2022 |
| Aug 25, 2022 | SOpen-market sale Common Stockindirect: By SymBiosis, LLC | -26,945 | $0.72 | $19k | 3,492,875 | Nov 14, 2022 |
| Aug 26, 2022 | SOpen-market sale Common Stockindirect: By SymBiosis, LLC | -60,628 | $0.62 | $37k | 3,432,247 | Nov 14, 2022 |
| Aug 29, 2022 | SOpen-market sale Common Stockindirect: By SymBiosis, LLC | -11,533 | $0.57 | $6,585 | 3,420,714 | Nov 14, 2022 |
| Aug 30, 2022 | SOpen-market sale Common Stockindirect: By SymBiosis, LLC | -13,487 | $0.57 | $7,634 | 3,407,227 | Nov 14, 2022 |
| Aug 31, 2022 | SOpen-market sale Common Stockindirect: By SymBiosis, LLC | -4,540 | $0.55 | $2,492 | 3,402,687 | Nov 14, 2022 |
| Sep 1, 2022 | SOpen-market sale Common Stockindirect: By SymBiosis, LLC | -8,297 | $0.55 | $4,530 | 3,394,390 | Nov 14, 2022 |
| Sep 2, 2022 | SOpen-market sale Common Stockindirect: By SymBiosis, LLC | -2,001 | $0.55 | $1,093 | 3,392,389 | Nov 14, 2022 |
| Sep 6, 2022 | SOpen-market sale Common Stockindirect: By SymBiosis, LLC | -6,403 | $0.55 | $3,490 | 3,385,986 | Nov 14, 2022 |
| Sep 7, 2022 | SOpen-market sale Common Stockindirect: By SymBiosis, LLC | -8,846 | $0.53 | $4,671 | 3,377,140 | Nov 14, 2022 |
| Sep 8, 2022 | SOpen-market sale Common Stockindirect: By SymBiosis, LLC | -4,592 | $0.52 | $2,397 | 3,372,548 | Nov 14, 2022 |
| Sep 9, 2022 | SOpen-market sale Common Stockindirect: By SymBiosis, LLC | -13,219 | $0.52 | $6,847 | 3,359,329 | Nov 14, 2022 |
| Sep 12, 2022 | SOpen-market sale Common Stockindirect: By SymBiosis, LLC | -1,700 | $0.54 | $920 | 3,357,629 | Nov 14, 2022 |
| Sep 13, 2022 | SOpen-market sale Common Stockindirect: By SymBiosis, LLC | -2,201 | $0.53 | $1,156 | 3,335,428 | Nov 14, 2022 |
| Sep 14, 2022 | SOpen-market sale Common Stockindirect: By SymBiosis, LLC | -2,301 | $0.52 | $1,203 | 3,353,127 | Nov 14, 2022 |
| Sep 15, 2022 | SOpen-market sale Common Stockindirect: By SymBiosis, LLC | -3,900 | $0.53 | $2,071 | 3,349,227 | Nov 14, 2022 |
Related signals
Other insiders at BiomX Inc. and this insider’s other filings.
| Score | Company | Insider | Value | Holdings | Filed |
|---|---|---|---|---|---|
| 60Notable | HLSQsell BiomX Inc. | Reuven Yeganeh director, owner | $4.9M 980,000 shares | -218% | |
| 60Notable | HLSQsell BiomX Inc. | Reuven Yeganeh director, owner | $3.4M 670,000 shares | -223% | |
| 12Weak | HLSQsell BiomX Inc. | OrbiMed Israel BioFund GP Limited Partnership owner | $9,280 24,344 shares | -0% | |
| 35Weak | HLSQsell BiomX Inc. | Assaf Oron Chief Business Officer | $4,072 10,914 shares | -100% | |
| 27Weak | HLSQbuy BiomX Inc. | OrbiMed Israel BioFund GP Limited Partnership owner | $85k 348,000 shares | +12% | |
| 18Weak | HLSQsell BiomX Inc. | Chidozie Ugwumba other | $107k 277,247 shares | -8% | |
| 13Weak | HLSQsell BiomX Inc. | Chidozie Ugwumba other | $27k 74,955 shares | -2% |
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.